Oxidation of a 1,4-di-iodobenzene having four adjacent p-tBu-C6H4 group (Ar′) substituents (1) yields the hypervalent iodine compound 1,4-[I(OAc)2]2-2,3,5,6-Ar′4-C6 (2), that undergoes cyclization to produce dicyclic di-iodonium salt (3).
Hypervalent iodine (HVI) compounds
are very important selective
oxidants often employed in organic syntheses. Most HVI compounds are
strongly associated in the solid state involving interactions between
the electropositive iodine centers and nearby electron lone pairs
of electronegative atoms. This study examines the impact of remote
substituents on select families of HVI compounds as means to achieve
predictable two-dimensional extended solid-state materials. Crystallographic
analyses of 10 HVI compounds from several related classes of λ3 organoiodine(III) compounds, (diacetoxyiodo)benzenes, (dibenzoatoiodo)benzenes,
[bis(trifluoroacetoxy)iodo]benzenes, and μ-oxo-[(carboxylateiodo)benzenes], provide insights into how remote
substituents and the choice of carboxylate groups can impact intermolecular
interactions in the solid state.
Iodonium ylides (ArI=CR(R")) represent unusual hypervalent iodine(III) sources of carbene equivalents. While their reactivity is well-described, their detailed structural chemistry is somewhat limited due to their thermal instability. Cyclic iodonium ylides typically have greater thermal stability than acyclic ylides, but so far few such materials have been examined by single crystal X-ray diffraction methods. This report details the synthesis of two cyclic iodonium ylides and their association in the solid state by intermolecular I•••O interactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.